A detailed history of National Pension Service transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, National Pension Service holds 223,617 shares of REGN stock, worth $153 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
223,617
Previous 191,160 16.98%
Holding current value
$153 Million
Previous $201 Million 17.0%
% of portfolio
0.23%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$1024.09 - $1201.76 $33.2 Million - $39 Million
32,457 Added 16.98%
223,617 $235 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $3.01 Million - $3.65 Million
3,411 Added 1.82%
191,160 $201 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $1.3 Million - $1.43 Million
1,439 Added 0.77%
187,749 $181 Million
Q4 2023

Feb 06, 2024

BUY
$775.18 - $881.7 $3.01 Million - $3.43 Million
3,887 Added 2.13%
186,310 $164 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $2.22 Million - $2.71 Million
3,212 Added 1.79%
182,423 $150 Million
Q2 2023

Aug 15, 2023

SELL
$700.03 - $830.35 $4.17 Million - $4.95 Million
-5,963 Reduced 3.22%
179,211 $129 Million
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $2.3 Million - $2.8 Million
3,386 Added 1.86%
185,174 $152 Million
Q4 2022

Feb 23, 2023

BUY
$705.89 - $766.39 $1.5 Million - $1.63 Million
2,131 Added 1.19%
181,788 $131 Million
Q4 2022

Feb 17, 2023

BUY
$705.89 - $766.39 $1.5 Million - $1.63 Million
2,131 Added 1.19%
181,788 $131 Million
Q3 2022

Feb 23, 2023

SELL
$573.97 - $724.32 $1.22 Million - $1.54 Million
-2,131 Reduced 1.17%
179,657 $124 Million
Q3 2022

Nov 17, 2022

BUY
$573.97 - $724.32 $4.06 Million - $5.12 Million
7,074 Added 4.1%
179,657 $124 Million
Q2 2022

Aug 17, 2022

BUY
$548.35 - $738.84 $8.3 Million - $11.2 Million
15,135 Added 9.61%
172,583 $102 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $1.13 Million - $1.33 Million
1,906 Added 1.23%
157,448 $110 Million
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $2.13 Million - $2.63 Million
-3,927 Reduced 2.46%
155,542 $98.2 Million
Q3 2021

Nov 18, 2021

SELL
$574.03 - $680.96 $861,619 - $1.02 Million
-1,501 Reduced 0.93%
159,469 $96.5 Million
Q2 2021

Aug 17, 2021

BUY
$472.8 - $558.54 $1.21 Million - $1.43 Million
2,553 Added 1.61%
160,970 $89.9 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $5.95 Million - $7.3 Million
13,314 Added 9.18%
158,417 $75 Million
Q4 2020

Feb 19, 2021

BUY
$478.3 - $607.98 $6.27 Million - $7.97 Million
13,101 Added 9.92%
145,103 $70.1 Million
Q2 2020

Aug 11, 2020

BUY
$493.32 - $643.92 $1.72 Million - $2.24 Million
3,482 Added 2.71%
132,002 $82.3 Million
Q1 2020

May 27, 2020

BUY
$336.18 - $494.43 $913,064 - $1.34 Million
2,716 Added 2.16%
128,520 $62.8 Million
Q4 2019

Feb 21, 2020

BUY
$274.13 - $376.51 $5.21 Million - $7.16 Million
19,021 Added 17.81%
125,804 $47.2 Million
Q3 2019

Nov 15, 2019

BUY
$273.46 - $318.39 $1.33 Million - $1.55 Million
4,867 Added 4.78%
106,783 $29.6 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $3.02 Million - $4.18 Million
10,084 Added 10.98%
101,916 $31.9 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $1.27 Million - $1.5 Million
3,422 Added 3.87%
91,832 $37.7 Million
Q4 2018

Feb 15, 2019

BUY
$335.82 - $403.04 $1.37 Million - $1.64 Million
4,075 Added 4.83%
88,410 $36.7 Million
Q3 2018

Nov 15, 2018

SELL
$351.14 - $408.51 $87,785 - $102,127
-250 Reduced 0.3%
84,335 $34.1 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $1.79 Million - $2.17 Million
6,301 Added 8.05%
84,585 $28.9 Million
Q1 2018

Apr 13, 2018

BUY
$315.82 - $393.78 $1.98 Million - $2.47 Million
6,275 Added 8.71%
78,284 $27 Million
Q4 2017

Jan 17, 2018

BUY
$358.63 - $469.95 $990,894 - $1.3 Million
2,763 Added 3.99%
72,009 $27.1 Million
Q3 2017

Oct 16, 2017

BUY
$431.38 - $504.0 $29.9 Million - $34.9 Million
69,246
69,246 $30.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $73.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.